EnsCat: clustering of categorical data via ensembling

Por Clarke, Bertrand S., Amiri, Saeid, Clarke, Jennifer L.
Publicado no BMC Bioinformatics (2016)

Current Advances in Immunotherapy for Glioblastoma

Por Mende, Abigail L., Schulte, Jessica D., Okada, Hideho, Clarke, Jennifer L.
Publicado no Curr Oncol Rep (2021)

Surgery, a prognostic marker for progression-free survival?: Reply

Por Clarke, Jennifer L., Ennis, Michele M., Prados, Michael D., Lamborn, Kathleen R.
Publicado em 2012

Relationship of glioblastoma multiforme to the subventricular zone is associated with survival

Por Jafri, Nazia F., Clarke, Jennifer L., Weinberg, Vivian, Barani, Igor J., Cha, Soonmee
Publicado em 2013

High dose weekly erlotinib achieves therapeutic concentrations in CSF and is effective in leptomeningeal metastases from epidermal growth factor receptor mutant lung cancer

Por Clarke, Jennifer L., Pao, William, Wu, Nian, Miller, Vincent A., Lassman, Andrew B.
Publicado em 2010

EVEROLIMUS (RAD001) AND THE MTOR PATHWAY IN LOW-GRADE GLIOMAS

Por Clarke, Jennifer L., Chang, Susan, Phillips, Joanna, Molinaro, Annette, Berger, Mitchel, Nelson, Sarah, Haas-Kogan, Daphne
Publicado em 2014

Six-month progression-free survival as an alternative primary efficacy endpoint to overall survival in newly diagnosed glioblastoma patients receiving temozolomide

Por Polley, Mei-Yin C., Lamborn, Kathleen R., Chang, Susan M., Butowski, Nicholas, Clarke, Jennifer L., Prados, Michael
Publicado em 2010

Conditional Probability of Survival in Patients With Newly Diagnosed Glioblastoma

Por Polley, Mei-Yin C., Lamborn, Kathleen R., Chang, Susan M., Butowski, Nicholas, Clarke, Jennifer L., Prados, Michael
Publicado em 2011

Case-Based Review: newly diagnosed glioblastoma

Por Johnson, Derek R., Fogh, Shannon E., Giannini, Caterina, Kaufmann, Timothy J., Raghunathan, Aditya, Theodosopoulos, Philip V., Clarke, Jennifer L.
Publicado no Neurooncol Pract (2015)

Glioma FMISO PET/MR Imaging Concurrent with Antiangiogenic Therapy: Molecular Imaging as a Clinical Tool in the Burgeoning Era of Personalized Medicine

Por Barajas, Ramon F., Krohn, Kenneth A., Link, Jeanne M., Hawkins, Randall A., Clarke, Jennifer L., Pampaloni, Miguel H., Cha, Soonmee
Publicado no Biomedicines (2016)

RISK FACTORS OF RADIOTHERAPY-INDUCED CEREBRAL MICROBLEEDS AND SERIAL ANALYSIS OF THEIR SIZE COMPARED TO WHITE MATTER CHANGES: A 7T MRI STUDY IN 113 ADULT PATIENTS WITH BRAIN TUMORS

Por Morrison, Melanie A., Hess, Christopher P., Clarke, Jennifer L., Butowski, Nicholas, Chang, Susan M., Molinaro, Annette M., Lupo, Janine M.
Publicado no J Magn Reson Imaging (2019)

Treatment-induced lesions in newly diagnosed glioblastoma patients undergoing chemoradiotherapy and Heat-Shock Protein vaccine therapy

Por Alcaide-Leon, Paula, Luks, Tracy L, Lafontaine, Marisa, Lupo, Janine M, Okada, Hideho, Clarke, Jennifer L, Villanueva-Meyer, Javier E
Publicado no J Neurooncol (2019)

Post-ER Stress Biogenesis of Golgi Is Governed by Giantin

Por Frisbie, Cole P., Lushnikov, Alexander Y., Krasnoslobodtsev, Alexey V., Riethoven, Jean-Jack M., Clarke, Jennifer L., Stepchenkova, Elena I., Petrosyan, Armen
Publicado no Cells (2019)

“Pulsatile” high-dose weekly erlotinib for CNS metastases from EGFR mutant non-small cell lung cancer

Por Grommes, Christian, Oxnard, Geoffrey R., Kris, Mark G., Miller, Vincent A., Pao, William, Holodny, Andrei I., Clarke, Jennifer L., Lassman, Andrew B.
Publicado em 2011

Short term dynamics of the sputum microbiome among COPD patients

Por Sinha, Rohita, Weissenburger-Moser, Lisa A., Clarke, Jennifer L., Smith, Lynette M., Heires, Art J., Romberger, Debra J., LeVan, Tricia D.
Publicado no PLoS One (2018)

Survivorship care planning in neuro-oncology

Por Leeper, Heather E, Acquaye, Alvina A, Bell, Susan, Clarke, Jennifer L, Forst, Deborah, Laack, Nadia N, Link, Michael J, Taylor, Jennie W, Armstrong, Terri S
Publicado no Neurooncol Pract (2018)

Phase II trial of 7 days on/7 days off temozolmide for recurrent high-grade glioma

Por Han, Seunggu J., Rolston, John D., Molinaro, Annette M., Clarke, Jennifer L., Prados, Michael D., Chang, Susan M., Berger, Mitchel S., DeSilva, Ashley, Butowski, Nicholas A.
Publicado em 2014

The Effect of Timing of Concurrent Chemoradiation in Patients With Newly Diagnosed Glioblastoma

Por Han, Seunggu J., Rutledge, William C., Molinaro, Annette M., Chang, Susan M., Clarke, Jennifer L., Prados, Michael D., Taylor, Jennie W., Berger, Mitchel S., Butowski, Nicholas A.
Publicado no Neurosurgery (2015)

Impact of Timing of Concurrent Chemoradiation for Newly Diagnosed Glioblastoma: A Critical Review of Current Evidence

Por Han, Seunggu J., Englot, Dario J., Birk, Harjus, Molinaro, Annette M., Chang, Susan M., Clarke, Jennifer L., Prados, Michael D., Taylor, Jennie W., Berger, Mitchel S., Butowski, Nicholas A.
Publicado no Neurosurgery (2015)

Randomized Phase II Trial of Chemoradiotherapy Followed by Either Dose-Dense or Metronomic Temozolomide for Newly Diagnosed Glioblastoma

Por Clarke, Jennifer L., Iwamoto, Fabio M., Sul, Joohee, Panageas, Katherine, Lassman, Andrew B., DeAngelis, Lisa M., Hormigo, Adília, Nolan, Craig P., Gavrilovic, Igor, Karimi, Sasan, Abrey, Lauren E.
Publicado em 2009